Last update:

Weight management news

The weight‑loss drug divide: Private prescribing is lowest where need is greatest

For many people living with obesity, Wegovy and Mounjaro offer the possibility of substantial weight loss without surgery. Yet data from one private provider points to a troubling divide: Prescription rates of these drugs ...

Improved health should guide obesity treatment, not weight loss alone

A new scientific statement released today by the Endocrine Society highlights the benefits of obesity treatment beyond weight loss, including improved overall health and reduced risk of conditions such as heart disease, sleep ...

Brain signaling mechanism may explain clozapine weight gain

Researchers at UT Southwestern Medical Center have identified a key brain signaling pathway that appears to drive the substantial weight gain often associated with clozapine, a widely used antipsychotic medication. The preclinical ...

Is poor sleep contributing to the country's weight issues?

Some 70% of teens trying to adapt to a fall schedule are missing out on sleep. Early bells and tough classes combine with delayed biological clocks during adolescence, keeping their nightly sleep duration during the school ...

Some hair loss in men is linked to weight loss drug use

Men already genetically at risk for the most common form of hair loss have a 7% added risk of losing their hair if they use drugs like Ozempic, Wegovy and Zepbound for type 2 diabetes and obesity, a new study shows.